CLOV CLOVER HEALTH INV CORP

Counterpart Assistant Gets Conversational

Counterpart Assistant Gets Conversational

New generative AI capabilities help physicians prep faster, manage complexity and deliver high-quality value-based care at scale

SAN FRANCISCO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI‑powered physician‑enablement platform, today announced the next step in the evolution of its flagship Counterpart Assistant (CA): generative AI capabilities that let clinicians engage with a patient’s longitudinal data in real time through AI chat. Instead of digging through countless clinical documents when researching patients, clinicians can now ask questions about a patient’s medical history in natural language within a protected health information (PHI)-safe environment. CA provides immediate responses with links to source documents, saving time and sharpening focus on patient care. This functionality is already live for select CA clinicians and is now being extended at no additional cost to eligible users. Interested providers can join the waitlist through their account manager or CA support.

This new interaction model turns the more than 100 data sources powering CA into real-time insights delivered through a simple conversation. Beyond medical history, CA can now also proactively generate pre-visit summaries, synthesizing dense information, flagging potential care opportunities and helping ensure physicians enter every exam room confident and prepared.

"Physicians can be drowning in data yet starved for actionable insights,” said Dr. David Tsay, MD, PhD, Chief Medical Officer at Counterpart Health. “This latest evolution of Counterpart Assistant gives them back time and clarity by making the patient's story instantly accessible so they can focus on delivering care.”

This release is a crucial building block in CA’s evolution and will soon power a wider range of functions across clinical workflows, further extending the ‘assistant’ in Counterpart Assistant through a flexible, interactive tool at the point of care. Together with integrated ambient scribing, these new capabilities highlight how CA is redefining patient care, reducing data overload, streamlining workflows and supporting value-based care. Like scribing, Clover Health is offering this new capability at no additional cost to all eligible clinicians using CA within its network.

"CA is improving how I prepare for visits," said Dr. Jeffrey Clemente, a family medicine physician. "It brings together key parts of the patient story, surfaces what's most relevant, and helps me get credible answers quickly - so I walk in better prepared and can focus on my patients."

This launch marks another leap forward in Counterpart Health’s mission to transform value-based care through clinically-oriented technology. Today’s conversational and generative capabilities lay the foundation for dozens of additional use cases that will further expand CA’s role as the physician’s indispensable digital assistant.

About Counterpart Health

, a subsidiary of Clover Health Investments, Corp., or Clover Health, is a leading AI-powered physician enablement platform transforming care delivery. Born out of Clover Health as Clover Assistant, Counterpart Health’s flagship software platform, Counterpart Assistant, provides clinically intuitive insights that help clinicians better manage chronic conditions and deliver high-quality care. Counterpart Health extends this powerful data-driven technology platform beyond Clover Health’s Medicare Advantage plan, bringing its benefits to a wider audience to improve patient outcomes and reduce healthcare costs nationwide. Several published studies demonstrate the technology’s impact on , , , and management, and .

Investor Relations:

Ryan Schmidt

Press Inquiries:



EN
25/09/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLOVER HEALTH INV CORP

 PRESS RELEASE

Clover Health to Report Fourth Quarter and Full Year 2025 Financial Re...

Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 WILMINGTON, Del., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Thursday, February 26, 2026. The Company’s management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company’s business and financial performance for the quarter. Fourth Quarter and Full Year 2025 Conference Webcast Detail...

 PRESS RELEASE

Clover Health Announces 53% Growth in Medicare Advantage Membership Du...

Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026 Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026.Disciplined, core-market growth, strong returning member retention, and improving cohort economics position Clover for compounding earnings and margin expansion.Powered by AI, Clover continues to bring industry-leading clinical quality to...

 PRESS RELEASE

Counterpart Health 2025 Results: How Better Clinical Decisions at Scal...

Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost Counterpart continues to demonstrate that unified data and real-time insights, delivered directly into the clinician’s workflow, drive measurable clinical and financial outcomes SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- , Inc. (“Counterpart” or the “Company”), a leading AI-powered physician-enablement platform and subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV), today released key 2025 highlights. The past year was defined by continued publication of research ...

 PRESS RELEASE

Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare C...

Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference WILMINGTON, Del., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andrew Toy, will present at the J.P. Morgan 2026 Healthcare Conference on Thursday, January 15, 2026, at 11:15 a.m. Eastern Time. A live webcast and replay of the presentation and Q&A session will be accessible on Clover Health's investor relations website at . About Clover Health:Clover Health (Nasdaq: CLOV) is a p...

 PRESS RELEASE

Clover Health to Participate in Upcoming 2025 Citi Global Healthcare C...

Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 Citi Global Healthcare Conference on Thursday, December 4, 2025, at 11:15 a.m. Eastern Time. A live webcast and replay of the presentation will be accessible on Clover Health's investor relations website at . About Clover Health:Clover Health (Nasdaq: CLOV) is a physician en...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch